Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Exchange Rate Effect for 8 consecutive years, with -$1000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 100.61% year-over-year to -$1000.0, compared with a TTM value of -$34000.0 through Sep 2025, down 115.81%, and an annual FY2024 reading of -$156000.0, down 257.58% over the prior year.
  • Exchange Rate Effect was -$1000.0 for Q3 2025 at X4 Pharmaceuticals, down from $139000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $363000.0 in Q4 2022 and bottomed at -$244000.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$14263.2, with a median of -$18000.0 recorded in 2024.
  • The sharpest move saw Exchange Rate Effect crashed 605.0% in 2022, then skyrocketed 872.22% in 2025.
  • Year by year, Exchange Rate Effect stood at -$116000.0 in 2021, then skyrocketed by 412.93% to $363000.0 in 2022, then crashed by 65.01% to $127000.0 in 2023, then crashed by 292.13% to -$244000.0 in 2024, then skyrocketed by 99.59% to -$1000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for XFOR at -$1000.0 in Q3 2025, $139000.0 in Q2 2025, and $72000.0 in Q1 2025.